2011 Vascular Research Initiatives Conference: basic foundations of translational research in vascular disease

Kenneth R Ziegler1, Alan Dardik,

  • 1Interdepartmental Program in Vascular Biology and Therapeutics and Department of Surgery, Yale University School of Medicine, 10 Amistad Street, Room 437, PO Box 208089, New Haven, CT 06520-8089, USA.

Insights

The 2011 Vascular Research Initiatives Conference (VRIC) showcased leading vascular research, fostering collaboration between surgeons and scientists. The event highlighted advancements in peripheral arterial disease, vascular biology, and regenerative medicine.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Surgical Innovation

Background:

  • The Society for Vascular Surgery (SVS) convenes the annual Vascular Research Initiatives Conference (VRIC).
  • The 2011 VRIC aligned with the American Heart Association's Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) meeting.
  • The conference aims to present cutting-edge vascular research and encourage interdisciplinary collaboration.

Framework:

  • Plenary sessions covered critical areas: peripheral arterial disease, vascular endothelium, thrombosis, aneurysms, and stem cells/tissue engineering.
  • Progress reports were presented by recipients of Society for Vascular Surgery (SVS) partner grants and National Institutes of Health K08 awardees.
  • Keynote addresses were delivered by distinguished researchers Linda Graham and Frank LoGerfo.

Implementation:

  • The 2011 VRIC was hosted in Chicago, Illinois, USA.
  • The event facilitated interaction between vascular surgeons and basic scientists.
  • It aimed to inspire academic vascular surgeons to pursue research careers.

Implications:

  • Fostered collaboration and knowledge exchange in vascular research.
  • Stimulated interest in academic vascular surgery and research.
  • Disseminated advancements in key areas of vascular disease and treatment.

Related Concept Videos

Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...